ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Essen-Zandvliet, E.
Right arrow Articles by Kerrebijn, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Essen-Zandvliet, E.
Right arrow Articles by Kerrebijn, K.
Eur Respir J 1994; 7: 63-68
Copyright © ERS Journals Ltd 1994

Clinical Trial

Remission of childhood asthma after long-term treatment with an inhaled corticosteroid (budesonide): can it be achieved? Dutch CNSLD Study Group

EE van Essen-Zandvliet, MD Hughes, HJ Waalkens, EJ Duiverman, and KF Kerrebijn

This study was undertaken in order to determine whether long-term treatment with inhaled corticosteroid can induce a remission in childhood asthma, and to decide when stabilization of airway responsiveness occurred. We therefore carried out, an extended follow-up of 28-36 months in one of two groups of children who participated in a long-term intervention study. This former study had shown that long-term (median follow-up 22 months) treatment with inhaled corticosteroid plus beta 2-agonist improves symptoms, airway calibre and airway responsiveness in children with asthma, compared with beta 2-agonist alone. On treatment with inhaled corticosteroid plus beta 2-agonist, airway calibre did not further improve after 4 months, whereas the provocative dose of histamine which causes a 20% fall in forced expiratory volume in one second (PD20) histamine showed gradual improvement without reaching an apparent plateau. Remission was defined as being symptom free during any 8 month period. Of the 58 children originally randomized to receive 0.2 mg salbutamol, plus 0.2 mg budesonide, t.i.d., five children withdrew: three due to lack of motivation, one for psychological reasons, and one due to a deterioration of asthma. One patient was hospitalized because of an asthma exacerbation. Airway calibre showed no improvement after 4 months up to 36 months. Mean PD20 histamine stabilized after 20 months at 2.1 doubling doses above baseline, but at a subnormal level of 80 micrograms. Symptoms improved during the first 18 months, and may have been improving further, but slowly, during the period between 18 and 36 months.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
 Am. J. Respir. Cell Mol. Bio.Home page
N. R. Locke, S. G. Royce, J. S. Wainewright, C. S. Samuel, and M. L. Tang
Comparison of Airway Remodeling in Acute, Subacute, and Chronic Models of Allergic Airways Disease
Am. J. Respir. Cell Mol. Biol., May 1, 2007; 36(5): 625 - 632.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A.M. Landstra, H.M. Boezen, D.S. Postma, and W.M.C. van Aalderen
Effect of intravenous hydrocortisone on nocturnal airflow limitation in childhood asthma
Eur. Respir. J., April 1, 2003; 21(4): 627 - 632.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
H Milgrom
Is there a role for treatment of asthma with omalizumab?
Arch. Dis. Child., January 1, 2003; 88(1): 71 - 74.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. BOUSQUET, P. K. JEFFERY, W. W. BUSSE, M. JOHNSON, and A. M. VIGNOLA
Asthma . From Bronchoconstriction to Airways Inflammation and Remodeling
Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1720 - 1745.
[Full Text]

Home page
 NEJMHome page
J. Balon, P. D. Aker, E. R. Crowther, C. Danielson, P. G. Cox, D. O'Shaughnessy, C. Walker, C. H. Goldsmith, E. Duku, and M. R. Sears
A Comparison of Active and Simulated Chiropractic Manipulation as Adjunctive Treatment for Childhood Asthma
N. Engl. J. Med., October 8, 1998; 339(15): 1013 - 1020.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. A. P. H. VERBERNE, C. FROST, E. J. DUIVERMAN, M. H. GROL, K. F. KERREBIJN, and the Dutch Paediatric Asthma Study Group
Addition of Salmeterol versus Doubling the Dose of Beclomethasone in Children with Asthma
Am. J. Respir. Crit. Care Med., July 1, 1998; 158(1): 213 - 219.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. J. BARNES, S. PEDERSEN, and W. W. BUSSE
Efficacy and Safety of Inhaled Corticosteroids . New Developments
Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): S1 - 53.
[Full Text] [PDF]

Home page
 NEJMHome page
F. E. R. Simons and The Canadian Beclomethasone Dipropionate-Salmetero
A Comparison of Beclomethasone, Salmeterol, and Placebo in Children with Asthma
N. Engl. J. Med., December 4, 1997; 337(23): 1659 - 1665.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. A. P. H. VERBERNE, C. FROST, R. J. ROORDA, H. van der LAAG, K. F. KERREBIJN, and The Dutch Paediatric Asthma Study Group
One Year Treatment with Salmeterol Compared with Beclomethasone in Children with Asthma
Am. J. Respir. Crit. Care Med., September 1, 1997; 156(3): 688 - 695.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
V. Gemou-Engesaeth, A. Bush, A. B. Kay, Q. Hamid, and C. J. Corrigan
Inhaled Glucocorticoid Therapy of Childhood Asthma Is Associated With Reduced Peripheral Blood T Cell Activation and `Th2-Type' Cytokine mRNA Expression
Pediatrics, May 1, 1997; 99(5): 695 - 703.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the European Respiratory Society.